Research and analysis

Whole-body monitoring: a high-resolution radionuclide identifier

This report (HPA-RPD-045) describes the use of a portable radionuclide identifier for preliminary measurements after a radiological incident.

• From: Public Health England
• Published: 1 October 2008

Documents

HPA-RPD-045: the use of high-resolution radionuclide identifier as a portable whole body monitor

Ref: ISBN 978-0-85951-627-3

PDF, 107 KB, 19 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

A portable radionuclide identifier (Detective^TM, Ortec, USA) has been calibrated so that it could be used following a radiological incident to measure radionuclides in whole body and also iodine-131 in thyroid. The system could be deployed very quickly as comparatively little equipment is required and the transportation can easily be achieved by one person. The rapid deployment would allow preliminary measurements to be made before the more sensitive transportable whole body monitor (currently operated by the Public Health England Centre for Radiation, Chemical and Environmental Hazards) is available.

An evaluation has shown that, for a range of gamma-emitting radionuclides which could be released following a radiological incident, the instrument can detect activities in the body from intakes that would result in effective doses of less than 1 millisievert. It therefore has sufficient sensitivity to be of value for monitoring. It is not sufficiently sensitive to be used for measurement of commonly encountered actinides in the body.

Published 1 October 2008